These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8203842)

  • 1. Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.
    Voorn GP; Kuyvenhoven J; Goessens WH; Schmal-Bauer WC; Broeders PH; Thompson J; Michel MF
    Antimicrob Agents Chemother; 1994 Mar; 38(3):487-93. PubMed ID: 8203842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.
    Voorn GP; Thompson J; Goessens WH; Schmal-Bauer WC; Broeders PH; Michel MF
    J Antimicrob Chemother; 1994 Apr; 33(4):785-94. PubMed ID: 8056697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
    Kaatz GW; Seo SM; Reddy VN; Bailey EM; Rybak MJ
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
    Cantoni L; Glauser MP; Bille J
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tolerance in cloxacillin treatment of experimental Staphylococcus aureus endocarditis.
    Voorn GP; Thompson J; Goessens WH; Schmal-Bauer W; Broeders PH; Michel MF
    J Infect Dis; 1991 Mar; 163(3):640-3. PubMed ID: 1995736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Fernandez J; Abbanat D; Shang W; He W; Amsler K; Hastings J; Queenan AM; Melton JL; Barron AM; Flamm RK; Lynch AS
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1476-84. PubMed ID: 22232278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Sakoulas G; Eliopoulos GM; Alder J; Eliopoulos CT
    Antimicrob Agents Chemother; 2003 May; 47(5):1714-8. PubMed ID: 12709345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
    Pavie J; Lefort A; Ploy MC; Massias L; Chau F; Garry L; Denis F; Fantin B
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2018-21. PubMed ID: 12760890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Marco F; de la Mària CG; Armero Y; Amat E; Soy D; Moreno A; del Río A; Almela M; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2538-43. PubMed ID: 18426900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tolerance in cloxacillin prophylaxis of experimental Staphylococcus aureus endocarditis.
    Voorn GP; Thompson J; Goessens WH; Schmall-Bauer W; Broeders PH; Michel MF
    J Infect Dis; 1992 Jul; 166(1):169-73. PubMed ID: 1607692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Chambers HF; Sande MA
    Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.
    Schaad HJ; Chuard C; Vaudaux P; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1703-10. PubMed ID: 7985998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical dose effect of continuously administered cloxacillin in treatment of tolerant Staphylococcus aureus endocarditis in rats.
    Voorn GP; Thompson J; Goessens WH; Schmal-Bauer WC; Broeders PH; Michel MF
    J Antimicrob Chemother; 1994 Mar; 33(3):585-93. PubMed ID: 8040122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.
    McGrath BJ; Kang SL; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2034-40. PubMed ID: 7811015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.
    Perdikaris GS; Pefanis A; Giamarellou H; Nikolopoulos A; Margaris EP; Donta I; Tsitsika A; Karayiannakos P
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1916-21. PubMed ID: 9303384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW; Boscia JA; Kobasa WD; Kaye D
    J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.